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Benzene-1,3-di-N-n-octylcarbamate (1), benzene-1-hydroxyl-3-N-n-octylcarbamate (2), ben-
zene-1,3-di-N-n-ocztylthiocarbamate (3), and benzene-1-hydroxyl-3-N-n-octylthiocarbamate
(4) are synthesized from 1,3-benzene-diol and are characterized as the pseudo-substrate
inhibitors of acetylcholinesterase, butyrylcholinesterase, cholesterol esterase, lipase, trypsin,
and chymotrypsin. For these six enzyme inhibitions by 1–4, the pKi values are linearly
correlated with their log ki values – Brønsted plots. Therefore, 1–4 inhibit these enzymes
through a common mechanism. Moreover, both pKi and log ki values for the inhibitions by
1,3, and 4 are linearly correlated with both pKi and log ki values for the inhibitions by 2,
respectively. Thus, the pKi values for the inhibitions by 2 are deﬁned as the nucleophilicity
constants of these enzymes (nenzyme). The log k2 values for the inhibitions by 1–4 are also
linearly correlated with the nenzyme values. Therefore, the nucleophilicity for serine hydrolases
and proteases toward 1–4 also applies the Swain–Scott correlations.
KEY WORDS: Structure–function relationship; serine hydrolase; serine protease; enzyme inhibition;
carbamate and thiocarbamate.
1. INTRODUCTION
Serine hydrolases such as acetylcholinesterase
(AChE, EC 3.1.1.7) (Bar-on et al., 2002; Bartolucci
et al., 1999; Quinn, 1987; Sussman et al., 1991),
butyrylcholinesterase (BChE, EC 3.1.1.8) (Loudwig
et al., 2003; Masson et al., 2002; Savini et al., 2003),
cholesterol esterase (CEase, EC 3.1.1.13) (Chen
et al., 1998; Wang et al., 1997), Pseudomonas species
lipase (PSL, EC 3.1.1.3) (Lang et al., 1998), trypsin
(EC 3.4.21.4) and chymotrypsin (CT, EC 3.4.21.1)
(Hedstrom et al., 1992; Kossiakoﬀ and Spencer,
1981; Kraut, 1977; Phillips and Fletterick, 1992; Seitz
and Shulman, 1982; Walsh, 1979) have a common
catalytic triad, Ser-His-Asp (or Glu). The active site
serines of these enzymes are located at the bottom of
a cavity and act as nucleophiles to attack the car-
bonyl groups of substrates or pseudo-substrate inhib-
itors. Two forms of cholinesterase coexist
ubiquitously throughout the body, AChE and BChE,
and although highly homologous, >65%, they are
products of diﬀerent genes on chromosomes 7 and 3
in humans, respectively (Quinn, 1987; Sussman et al.,
1991). Both subtype unselective cholinesterase and
AChE-selective inhibitors have been used in Alzhei-
mer’s disease to amplify the action of acetylcholine at
remaining cholinergic synapses within the Alzhei-
mer’s disease brain. Rivastigmine (Exelon) (Fig. 1) is
a carbamate inhibitor of AChE and is used in the
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treatment for patients with mild to moderately severe
Alzheimer’s disease (Bar-on et al., 2002). The X-ray
crystal structures of AChE have revealed that AChE
contains a catalytic triad similar to that present in
other serine hydrolases. It has also revealed that this
triad is located near the bottom of a deep and narrow
gorge about 20 A˚ in depth (Sussman et al., 1991).
The X-ray crystal structure of BChE has been
recently reported (Loudwig et al., 2003; Masson et al.,
2002). Cholesterol esterase (CEase), also known as
bile salt-activated lipase, catalyzes the hydrolysis of
dietary cholesterol esters, triacylglycerols, phospho-
lipids, and vitamin esters. Although diﬀerent bile
salt-activation mechanisms have been proposed, the
active sites of CEase from X-ray crystal structures
are similar to that of lipase (Chen et al., 1998; Wang
et al., 1997). The X-ray crystal structures of CEase
have revealed that the enzyme contains a catalytic
triad similar to that present in other serine hydrolases
and an acyl chain binding site. The X-ray crystal
structures of Pseudomonas cepacia lipase (PCL) have
revealed that the enzyme contains a catalytic triad
similar to that present in other serine hydrolases and
three acyl chain binding sites (Lang et al., 1998). CT
and trypsin are strikingly similar. The primary struc-
tures of both enzymes are about 40% identical (Hed-
strom et al., 1992; Kossiakoﬀ and Spencer, 1981;
Kraut, 1977; Phillips and Fletterick, 1992; Seitz and
Shulman, 1982; Walsh, 1979). Furthermore, both en-
zymes have a nucleophilic Ser in their catalytic triads.
CT has a hydrophobic pocket that binds the side
chains of aromatic or bulky hydrophobic amino resi-
dues of substrates. Trypsin has a negatively charged
Asp residue at the bottom of the binding pocket,
which allows the enzyme to bind the positively
charged side chains residues of substrates.
Quantitative structure activity relationships
(QSARs) represent an attempt to correlate structural
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Fig. 1. Structures of inhibitors 1–4 and rivastigmine (Exelon).
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properties of compounds with activities (Isaacs,
1995; Lowry and Richardson, 1992; March, 1992;
Thomas, 2000). These chemical descriptors, which
include parameters to account for hydrophobicity,
electronic, inductive, or polar properties, and steric
eﬀects, are determined empirically or by calcula-
tions (Thomas, 2000). Many biological activities
and chemical reactivities are correlated with the
Hammett equation (Eq. (1)) (Isaacs, 1995; Lowry
and Richardson, 1992; March, 1992; Thomas,
2000).
log k or logK ¼ hþ qr ð1Þ
In Eq. (1), h, q, and r are the log k0 or log K0 val-
ues, intensity factor for electronic (polar) eﬀect, and
Hammett substituent constant, respectively. A tradi-
tional means of doing QSAR in organic chemistry is
the use of linear free energy relationships (LFERs)
that links changes in rate constant for a reaction to
changes in its equilibrium constant as the structure
of the substrates or inhibitors is altered – Brønsted
or Hammett plots (Eq. (2)) (Isaacs, 1995; Lowry
and Richardson, 1992; March, 1992).
log k ¼ hþ b logK ð2Þ
Fersht et al. (1986) have found that Brønsted plots
may be applied to enzymatic reactions for variation
of the structure of an enzyme with mutation. There-
fore, quantitative structure–function relationships
(QSFRs) represent an attempt to correlate struc-
tural properties of enzymes (or proteins) with enzy-
matic reactivities toward a common substrate (or
inhibitor). In this paper, we report that Brønsted
plots may be also applied to enzymatic reactions for
variation of the structure of enzymes, serine hydro-
lases and serine proteases.
Carbamate and thiocarbamate inhibitors, such
as rivastigmine (Fig. 1), aryl carbamates, and
aryl thiocarbamates, are characterized as the pseu-
do-substrate inhibitors of AChE, BChE, CEase, and
PSL (Bar-on et al., 2002; Hosie et al., 1987; Lin and
Chouhwang, 2001; Lin and Lai, 1995, 1996; Lin
et al., 1999a, b, 2000). In the presence of substrate,
the kinetic scheme for pseudo-substrate inhibitions
of serine hydrolases by carbamate or thiocarbamate
inhibitors is proposed (Fig. 2). Since this inhibition
follows ﬁrst-order kinetics over observed time peri-
od for steady-state kinetics, hydrolysis rate of
carbamyl (or thiocarbamyl) enzyme EI’ must be sig-
niﬁcantly slower than EI’ formation rate (k2k3).
Therefore, values of Ki and k2 can be calculated
from Eq. (3) (Hosie et al., 1987). In Eq. (3), the
kapp values are ﬁrst-order rate constants which are
obtained by Hosie’s method. The bimolecular rate
constant, ki=k2/Ki, is related to overall inhibitory
potency.
kapp ¼ k2½I=ðKið1þ ½S=kmÞ þ ½IÞ ð3Þ
The nucleophilicity of nucleophiles for SN2 reac-
tions in organic chemistry is linearly correlated
against the Swain–Scott equation (Eq. (4)), where
k0 refers to a standard nucleophile (water), and s is
the susceptibility constant expressing sensitivity of
the rate to nucleophilicity (Isaacs, 1995; Lowry and
Richardson, 1992; March, 1992). Analogies with the
Hammett equation (Eq. (1)) are obvious.
log kNu ¼ log k0 þ sn ð4Þ
The value of s is deﬁned for methyl bromide substitu-
tion in water as s=1, with other systems relative to
this. Although all serine hydrolase and protease-cata-
lyzed reactions use a common nucleophile, Ser, yet
the nucleophilicity for these enzymes is quite diﬀer-
ent. Therefore, we report here that the necleophilicity
for serine hydrolases and protease, such as AChE,
BChE, CEase, PSL, CT, and trypsin, is linearly
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Fig. 2. Kinetic scheme for the pseudo-substrate inhibition of carbamates or thiocarbamates in the presence of substrate. E, enzyme;
S, substrate; ES, acylenzyme intermediate; I, carbamate or thiocarbamate, EI, enzyme-inhibitor tetrahedral intermediate; EI’, carbamyl
(or thiocarbamyl) enzyme intermediate; P, the ﬁrst product; Q, the second product.
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correlated against Eq. (4) toward carbamates and thi-
ocarbamates since these compounds inhibit all six
enzymes through the same pseudo-substrate inhibition
mechanism (Fig. 2) (Bar-on et al., 2002; Hosie et al.,
1987; Lin and Chouhwang, 2001; Lin and Lai, 1995,
1996; Lin et al., 1999a, b, 2000). Thus, benzene-
1,3-di-N-n-octylcarbamate (1) (Fig. 1), benzene-1-hy-
droxy-3-N-n-octylcarbamate (2), benzene-1,3-di-N-n-
octylthio- carbamate (3), and benzene-1-hydroxy-3-
N-n-octylthiocarbamate (4) may be used as standard
electrophiles or pseudo-substrates to probe the nucle-
ophilicity of serine hydrolases and proteases.
2. MATERIALS AND METHODS
2.1. Materials
All chemicals were of the highest grade avail-
able. Silica gel used in liquid chromatography and
thin-layer chromatography plates were obtained
from Merk. Electrophorus electricus AChE, horse
serum BChE, Porcine pancreatic CEase, trypsin
(Type II-S, ca. 1800 units/mg solid), PSL (Type
XIII, ca. 25 units/mg solid), bovine pancreatic CT
(Type II, ca. 50 units/mg protein) were obtained
from Sigma. Acetylthiocholine, butyrylthiocholine
5,5¢-dithio-bis-2- nitrobenzoate, p-nitrophenylbuty-
rate were also obtained from Sigma.
2.2. Instrumental Methods
1H and 13C NMR spectra were recorded at 400
and 100 MHz, respectively, on a Varian-Gemini 400
spectrometer. All steady state kinetic data were
obtained from a UV–visible spectrometer (Agilent
8453) with a cell holder circulated with a water bath.
2.3. Synthesis of Inhibitors 1–4
Benzene-1,3-di-N-n-octylcarbamate (1) and benzene-
1-hydroxy-3-N-n-octylcarbamate (2) (Fig. 1) were synthe-
sized from condensation of 1,3-benzene-diol with 2 eqs.
of n-octyl isocyanate in the presence of 2 eqs. of triethyl-
amine in tetrahydrofuran at 25C for 24 h yielding a
mixture of 1 (35–45%) and 2 (25–35%). 1 and 2 were
then separated by liquid chromatography. Benzene-
1,3-di-N-n-octylthiocarbamate (3), and benzene-1-
hydroxy-3-N-n-octylthiocarbamate (4) were synthe-
sized from condensation of 1,3-benzene-diol with
2 eqs. of n-octyl isothiocyanate in the presence of
2 eqs. of triethylamine in tetrahydrofuran at reﬂux
temperature for 24 h yielding a mixture of 3 (30–
40%) and 4 (20–35%). 3 and 4 were then separated
by liquid chromatography (silica gel, hexane-ethyl
acetate).
Benzene-1,3-di-N-n-octylcarbamate (1): 1H NMR
(CDCl3, 400 MHz) d/ppm 0.86 (t, 6H, x-CH3), 1.26–
1.30 (m, 20H, c to x-1-CH2), 1.52–1.55 (m, 4H, b-
CH2), 3.20 (q, 4H, a-CH2), 4.97 (br. s, 2H, NH),
6.94–7.28 (m, 4H, aromatic H’s); 13C NMR (CDCl3,
100 MHz) 14.03 (x-CH3), 22.58, 26.69, 29.14, 29.17,
and 29.73 (c to x-1-CH2), 31.74 (b-CH2), 41.24 (a-
CH2), 115.33, 118.22, 129.24, 151.48 and 154.16
(aromatic C’s and carbamate C’s).
Benzene-1-hydroxy-3-N-n-octylcarbamate (2): 1H
NMR (CDCl3, 400 MHz) d/ppm 0.90 (t, 3H,
x-CH3), 1.28–1.30 (m, 10H, c to x-1-CH2), 1.52–
1.55 (m, 2H, b-CH2), 3.22 (q, 2H, a-CH2), 5.05 (br.
s, 1H, OH), 5.23 (br. s, 1H, NH), 6.56–7.10 (m, 4H,
aromatic H’s); 13C NMR (CDCl3, 100 MHz) 13.99
(x-CH3), 22.54, 26.65, 29.10, 29.13, and 29.57 (c to
x-1-CH2), 31.69 (b-CH2), 41.24 (a-CH2), 109.35,
112.89, 112.97, 129.62, 151.44, 155.32, and 157.16
(aromatic C’s and carbamate C).
Benzene-1,3-di-N-n-octylthio- carbamate (3): 1H
NMR (CDCl3, 400 MHz) d/ppm 0.80 (t, 6H,
x-CH3), 1.32–1.34 (m, 20H, c to x-1-CH2), 1.52–1.68
(m, 4H, b-CH2), 3.39 (q, 4H, a-CH2), 5.11 (br. s, 2H,
NH), 6.68–7.17 (m, 4H, aromatic H’s); 13C NMR
(CDCl3, 100 MHz) 14.03 (x-CH3), 22.59, 26.70,
29.13, 29.17, and 29.65 (c to x-1-CH2), 31.73 (b-
CH2), 45.91 (a-CH2), 110.42, 113.36, 114.93, 129.76,
153.94, and 156.43 (aromatic C’s and carbamate C’s).
Benzene-1-hydroxy-3-N-n-octylthiocarbamate
(4): 1H NMR (CDCl3, 400 MHz) d/ppm 0.85 (t, 3H,
x-CH3), 1.26–1.30 (m, 10H, c to x-1-CH2), 1.50–1.55
(m, 2H, b-CH2), 3.23 (q, 2H, a-CH2), 4.96 (br. s, 1H,
OH), 5.11 (br. s, 1H, NH), 6.59–7.11 (m, 4H,
aromatic H’s); 13C NMR (CDCl3, 100 MHz) 14.05
(x-CH3), 22.61, 26.72, 29.16, 29.67, and 29.72 (c to
x-1-CH2), 31.76 (b-CH2), 41.34 (a-CH2), 109.44,
112.97, 113.10, 129.77, 151.62, 155.11, and 157.07
(aromatic C’s and carbamate C).
2.4. Data Reduction
Origin (version 6.0) was used for the linear and
nonlinear least-squares curve ﬁttings.
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2.5. Inhibitions of Serine Hydrolases and Protease
by 1–4
The inhibition reactions of AChE were
determined by the Ellman assay (Ellman et al.,
1961) as described before (Lin et al., 1999a). The
AChE-catalyzed hydrolysis of acetylthiocholine
(0.1 mM) in the presence of 5,5¢-dithio-bis-2-
nitrobenzoate (0.1 mM) and inhibitors 1–4 were
followed continuously at 410 nm on a UV–visible
spectrometer at 25C, pH 7.1. The inhibition reac-
tions of BChE-catalyzed hydrolysis of butyrylthi-
ocholine (0.1 mM) by inhibitors 1–4 were also
determined by the Ellman assay as described be-
fore (Lin et al., 1998). All the other procedures
were the same as described in the AChE inhibi-
tions. The inhibition reactions of CEase were
determined by the Hosie assay Hosie et al., 1987)
as described before (Lin and Lai, 1995, 1996,
1999b, 2000). Porcine pancreatic CEase-catalyzed
hydrolysis of p-nitrophenylbutyrate (0.5 mM) and
inhibitors 1–4 in the presence of triton X-100
(0.5% w/w, ca. 7.7 mM) were followed continu-
ously at 410 nm on a UV–visible spectrometer
(Agilent 8453) at 25C, pH 7.1. The inhibition
reactions of PSL-catalyzed hydrolysis of p-nitro-
phenylbutyrate (0.5 mM) by inhibitors 1–4 were
also determined by the Hosie assay as described
before (Lin and Chouhwang, 2001; Lin et al.,
1999b). All the other procedures were the same as
described in the CEase inhibitions. The inhibitions
of trypsin- and CT-catalyzed hydrolysis of p-nitro-
phenylbutyrate (0.5 mM) by inhibitors 1–4 were
also determined by the Hosie assay. All the other
procedures were the same as described in the
CEase inhibitions. The Ki (Table 1) and k2 (Ta-
ble 2) values were obtained from the nonlinear
least-squares of curve ﬁttings of the kapp values
versus inhibition concentration ([I]) plot against
Eq. (2).
3. RESULTS
Inhibitors 1–4 (Fig. 1) were synthesized from
condensation of 1,3-benzene-diol with butyl isocya-
nate or butyl isothiocyanate in the presence of tri-
ethylamine. Inhibitors 1–4 were all characterized as
the pseudo-substrate inhibitors of AChE, BChE,
CEase, PSL, trypsin, and CT (Tables 1–3). For
these enzyme inhibitions by 1–4, the pKi values
were linearly correlated with their log ki values –
Brønsted or Hammett plots (Isaacs, 1995; Lowry
and Richardson, 1992; March, 1992) (Fig. 3 and
Table 4). Therefore, 1–4 inhibited these enzymes
through a common mechanism. Moreover, both pKi
and log ki values for the inhibitions by 1,3, and 4
were linearly correlated with both pKi and log ki
values for the inhibitions by 2, respectively (Figs. 4
and 5 and Tables 5 and 6). Thus, the pKi values for
Table 1. The Ki values (in lM)
a for the inhibitions of AChE, BChE, CEase, PSL, trypsin, and CT by 1–4
1 2 3 4
AChE 2.3±0.3 2.2±0.3 1.8±0.1 1.06±0.09
BChE 1.6±0.3 1.7±0.3 2.5±0.2 1.1±0.3
CEase 1.2±0.1 1.5±0.3 1.30±0.08 0.82±0.06
PSL 2.7±0.3 2.2±0.4 4.55±0.03 0.9±0.1
Trypsin 18±9 15±2 40±1 11±2
CT 10.1±0.6 8±4 28±4 6.0±0.6
a Obtained from the nonlinear least-squares curve ﬁttings of kapp versus [I] plot against Eq. (2) by Hosie’s method (Hosie et al., 1987).
Table 2. The k2 values (in 10
)3 s)1)a for the inhibitions of AChE, BChE, CEase, PSL, trypsin, and CT by 1–4
1 2 3 4
AChE 10.4±0.2 5.29±0.09 2.76±0.03 18.54±0.02
BChE 8.5±0.7 10±1 16.0±0.3 29 ±1
CEase 6.4±0.5 7.0±0.2 6.18±0.02 5.68±0.07
PSL 16.6±0.4 6.6±0.4 9.76±0.07 11.4±0.3
Trypsin 0.37±0.05 0.93±0.03 1.1±0.2 0.58±0.02
CT 0.55±0.01 0.57±0.06 1.05±0.05 0.40±0.04
a Obtained from the nonlinear least-squares curve ﬁttings of kapp versus [I] plot against Eq. (2) by Hosie’s method (Hosie et al., 1987).
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the inhibitions by 2 were deﬁned as the enzyme
nucleophilicity constants (nenzyme) (Fig. 6). The log
k2 values for the inhibitions by 1–4 were also line-
arly correlated with the nenzyme values (Fig. 7 and
Table 7). Therefore, the nucleophilicity for serine
hydrolases and proteases toward 1–4 also applied
the Swain–Scott correlations (Eq. (4)). Thus, the pki
values of inhibitors 1,3, and 4 were linearly corre-
lated with nenzyme (Fig. 6) against Eq. (5) (Fig. 5
and Table 6),
pKiðlog ki; or log k2Þ ¼ hþ snenzyme ð5Þ
where the nenzyme values referred to the pKi values
for the enzyme inhibitions by inhibitor 2 and repre-
sented the nucleophilicity constants of the enzyme,
and s was the susceptibility constant expressing the
sensitivity for nucleophilicity of the enzyme. The
value of s was deﬁned for the enzyme inhibitions by
inhibitor 2 as s=1, with other inhibition systems rel-
ative to this (Table 6). Thus, the order of the nenzyme
values were deﬁned as follows: CEase > BChE >
AChE  PSL > CT > trypsin (Fig. 6).
4. DISCUSSION
4.1. Inhibitory Potencies of 1–4
Inhibitors 1–4 (Fig. 1) are all characterized as
the pseudo-substrate inhibitors (Fig. 2) of AChE,
BChE, CEase, PSL, trypsin, and CT (Tables 1–3).
Among inhibitors 1–4, thiocarbamate 4 is the most
potent inhibitors of these six enzymes when com-
pared their ki (Table 1), k2 (Table 2), and ki
(Table 3) values. The possible reason for this is
because the thiocarbamate sulfur of inhibitor 4
Table 3. The Ki values (in M
)1 s)1)a for the inhibitions of AChE, BChE, CEase, PSL, trypsin, and CT by 1–4
1 2 3 4
AChE 4500±600 2400±300 1530±90 17000±1000
BChE 5000±1000 5900±200 6400±500 26400±300
CEase 5300±600 4700±900 4800±300 6900±400
PSL 6100±700 3000±600 2150±20 12700±300
Trypsin 20±10 62±8 28±5 53±2
CT 54±3 70±40 38±6 70±10
aki ¼ k2=Ki.
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Fig. 3. Plot of pKi against log ki for Eq. (2) for the inhibitions of AChE, BChE, CEase, PSL, trypsin, and CT by inhibitor 1.
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more stabilizes the oxyanion hole of the enzyme
than the carbamate carbonyl oxygens of inhibitors 1
and 2 and the thiocarbamate sulfur of inhibitor 3.
When the inhibitor binds tightly in the oxyanion
hole of the enzyme, distances for the two- or three-
pronged hydrogen bonds (Harel et al., 1996; Zhan
et al., 2003; Zhang et al., 2002) between the sulfur
atom of the inhibitor and the peptidic NH groups
in the oxyanion hole are shorter than those between
the oxygen atom of the inhibitor and the peptidic
NH groups in the oxyanion hole due to a relatively
larger size of the sulfur atom. On the other hand,
the least potent thiocarbamate 3 may be due to the
fact that an oversize eﬀect from the second sulfur
atom of the inhibitor reduces the tightness for the
inhibitor binding in the oxyanion hole of the en-
zyme.
4.2. Brønsted or Hammett Correlations
of the Inhibitions
For these enzyme inhibitions by 1–4, the pKi val-
ues are linearly correlated with their log ki values –
Brønsted or Hammett plots (Fig. 3 and Table 4). The
b values about 0.4 (Table 4) indicate that about 40%
of the change in binding energy on forming the carb-
amyl or thiocarbamyl enzyme (EI’ in Fig. 2) occurs
at the stage of formation of the tetrahedral interme-
diate (EI in Fig. 2) (Fersht et al., 1986). Therefore,
1–4 inhibit these enzymes through a common mecha-
nism (Fig. 2).
4.3. Swain–Scott Correlations of the Inhibitions
Both pKi and log ki values for the inhibitions by
1, 3, and 4 are linearly correlated with both pKi and
log ki values for the inhibitions by 2, respectively
(Figs. 5 and 6 and Tables 5 and 6). Thus, pKi for the
inhibitions by 2 is then deﬁned as the nucleophilicity
for the serine hydrolase or protease (nenzyme)
(Fig. 6). The log k2 values for the inhibitions by 1–4
1.5 2.0 2.5 3.0 3.5 4.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
CEase
PSL
BChEAChE
CT
Trypsin
lo
g 
 k
i  f
or
 1
log  ki
 
for 2
Fig. 4. Plot of log ki for the enzyme inhibitions by inhibitor 1 against those by inhibitor 1.
Table 4. Correlations of the pKi values with the log Ki values
against Eq. (2)a for the inhibitions of AChE, BChE, CEase, PSL,
trypsin, and CT inhibitions by 1–4
Inhibitors b h Rb
1 0.39±0.06 4.3±0.2 0.961
2 0.44±0.05 4.2±0.1 0.978
3 0.56±0.09 3.6±0.3 0.951
4 0.37±0.06 4.5±0.2 0.952
a pKi ¼ hþ b log ki:
b Correlation coeﬃcient.
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are also linearly correlated with the nenzyme values
(Table 7). Therefore, the nucleophilicity for serine
hydrolases and proteases toward 1–4 applies the
Swain–Scott correlations (Eq. (5)).
4.4. Nucleophilicity Constants (nenzyme)
of the Enzymes
All six enzymes in this study belong to the ser-
ine hydrolase or protease family and the enzymes use
the Ser residue as a common nucleophile in catalysis.
Therefore, the nucleophilicity for the enzymes shall
be about the same if the nucleophilicity of the Ser
residues of the enzymes is the only factor for the
enzymatic reactions. Since the nenzyme values (Fig. 6)
are varied with enzymes, the nenzyme values may also
depend on other factors such as active site shapes
and oxyanion holes. The higher nenzyme value (Fig. 6)
for an enzyme indicates that this enzyme acts as a
better nucleophile than the others. The nenzyme value
of 5.77 for BChE is larger than that for AChE
(5.66). The possible reasons are as follows. The pep-
tidic NH groups in the oxyanion hole of BChE more
stabilizes the negatively charged tetrahedral interme-
diate 6 (Fig. 8) than the peptidic NH groups in the
oxyanion hole of AChE does. The more open acyl
pocket for BChE speciﬁcity toward bulky substrates
or inhibitors is also responsible for stabilization of
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Fig. 5. Plots of pKi for the enzyme inhibitions by 1(squares), 3 (circles) and 4 (triangles) against nenzyme (Fig. 7). Results for these linear
correlations were summarized in Table 6.
Table 5. Correlations of the log ki values for the inhibitions of
AChE, BChE, CEase, PSL, trypsin, and CT inhibitions by 1, 3,
and 4 with those by 2 against Eq. (6)a
Inhibitors s h Rb
1 1.2±0.1 )0.7±0.3 0.985
2 1 0 1
3 1.14±0.04 )0.6±0.1 0.998
4 1.3±0.1 )0.6±0.4 0.979
a (log ki)1, 3, 4=h+s(log ki)2. (6)
b Correlation coeﬃcient.
Table 6. Correlations of the pKi values for the inhibitions of
AChE, BChE, CEase, PSL, trypsin, and CT inhibitions by 1–4
with nenzyme
a against Eq. (5)b
Inhibitors s h Rc
1 1.21±0.07 )1.2±0.4 0.993
2 1d 0 1
3 1.5±0.2 )3±1 0.966
4 1.17±0.09 )0.7±0.5 0.987
a Deﬁned as the pKi values for the inhibitions of AChE, BChE,
CEase, PSL, trypsin, and CT inhibitions by 2 (Fig. 7).
b Correlation against pKi=h+snenzyme.
c Correlation coeﬃcient.
d Deﬁned as unity.
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the tetrahedral intermediate 6 (Fig. 8) (Zhan et al.,
2003). It seems that the inhibitor is more easy to en-
ter the active gorge of BChE than to enter the active
gorge of AChE (Bar-on et al., 2002; Bartolucci
et al., 1999; Quinn, 1987; Sussman et al., 1991) due
to a relatively larger active site gorge of the former
(Loudwig et al., 2003; Masson et al., 2002; Savini
et al., 2003; Zhan et al., 2003).
Like BChE, CEase has a larger binding pocket
for substrates (Chen et al., 1998; Wang et al., 1997).
Although PSL has three acyl chain binding sites,
only one of them is the catalytic site (Lang et al.,
1998). Therefore, inhibitors 1–4 are more diﬃcult to
bind to the catalytic site of PSL than to bind to
that of CEase. On the other hand, small nenzyme val-
ues for trypsin and CT (Fig. 6) are probably due to
lack of any acyl chain binding site in both enzymes
(Hedstrom et al., 1992; Kossiakoﬀ and Spencer,
1981; Kraut, 1977; Phillips and Fletterick, 1992;
Seitz and Shulman, 1982; Walsh, 1979). All s values
about unity (Table 6) conﬁrm that all inhibition
reactions by inhibitors 1–4 proceed with a common
mechanism in the Ki step (Figs. 2 and 8).
The log k2 values for the enzyme inhibitions by
1–4 are further correlated with nenzyme for the
AChE BChE CEase PSL Trypsin CT
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Fig. 6. Enzyme nucleophilicity constant (nenzyme). The nenzyme val-
ues were deﬁned as the pKi values for the enzyme inhibitions by
inhibitor 2.
Table 7. Correlations of the log k2 values for the inhibitions of
AChE, BChE, CEase, PSL, trypsin, and CT inhibitions by 1–4
with nenzyme
a against Eq. (5)b
Inhibitors s h Rc
1 1.6±0.3 )11±2 0.934
2 1.2±0.2 )9±1 0.931
3 1.0±0.3 )8±2 0.856
4 1.7±0.4 )12±2 0.889
a Deﬁned as the pKi values for the inhibitions of AChE, BChE,
CEase, PSL, trypsin, and CT inhibitions by 2 (Fig. 7).
b Correlation against log k2=h+s nenzyme.
c Correlation coeﬃcient.
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Fig. 7. Plots of log k2 for the enzyme inhibitions by 1 (squares), 2 (circles), 3 (triangles), and 4 (diamonds) against nenzyme (Fig. 7).
Results for these linear correlations were summarized in Table 7.
41Structure–Function Relationships of Serine Hydrolases and Proteases
Ki
k2
O
N
H2
O OH
+
OH
Ser
O
O-
N
H2
O OH
+
Ser
Ser
O
O
H2N
+
HO OH
OH
O
N
H2
O OH
+
Ser
O
O-
N
H2 O OH
+
Ser
oxyanion 
hole
oxyanion 
hole
active site
active site
active site
Tetrahedral intermediate
 6
oxyanion 
hole
Carbamyl enzyme
intermediate
9
oxyanion 
hole
active site
Transition state
5
oxyanion 
hole
active site
Transition state
7
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enzyme inhibitions by 2 (Fig. 7 and Table 7). These
linear correlations indicate similar interactions be-
tween the enzymes and inhibitors 1–4 in the transi-
tion states of both Ki and k2 steps (transition states
5 and 7 in Fig. 8). In other words, the k2 steps in-
volve early transition states; therefore, the transition
state 7 resembles the tetrahedral intermediate 6
(Fig. 8). That all s values are about unity (Fig. 7
and Table 7) conﬁrms the same mechanism for all
k2 steps (Figs. 2 and 8).
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